2017 Feb 10
We Are Weill Cornell Medicine: Dr. Christopher Barbieri
Christopher Barbieri, M.D., Ph.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Feb 09
Collaboration Employs New Strategies to Study the Spread of Cancer
Video of If cancer didn’t metastasize, or spread, it would be easy to cure, says Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. “We could merely cut it out, and... Read more
2017 Feb 09
Collaboration employs new strategies to study the spread of cancer
Feature about the new Center on the Physics of Cancer Metabolism collaboration between Ithaca and NYC. Read more
2017 Feb 09
Weill Cornell Medicine scientists seek to improve ovarian cancer therapies
Juan Cubillos-Ruiz and colleagues have been awarded a grant to define the role of a potentially crucial biomarker in the treatment of ovarian cancer tumors. Read more
2017 Feb 08
Medical Marvels: Life-saving treatment for chronic leukemia
Richard Furman, M.D. and patient Robert Frank Azopardi were recently featured on the abc7NY Medical Marvels series. Read more
2017 Feb 06
Old drug may provide new hope to melanoma patients
Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D. Read more
2017 Feb 02
Expert discusses upcoming agents to treat follicular lymphoma
John Leonard, M.D. discusses advancements in the treatment of follicular lymphoma. Read more
2017 Feb 01
Artificial Intelligence helps identify effective cancer drug combinations
Artificial intelligence (AI) can help scientists predict what combinations of already existing drugs may work in different types of cancer, according to two new studies from the lab of Olivier Elemento, Ph.D. Read more
2017 Jan 31
Grad student honored for teaching, cancer patient program
Peter DelNero, a doctoral candidate in biomedical engineering who works in the lab of Cornell University associate Claudia Fischbach-Teschl, Ph.D, has received the 2017 K. Patricia Cross Future Leaders Award. DelNero is one of eight graduate students nationwide to receive this prestigious award out of more than 250 nominees from 127 institutions. Read more
2017 Jan 30
Martin discusses ibrutinib-palbociclib combo in mantle cell lymphoma
Peter Martin, M.D., discusses the results of a trial testing the combination of ibrutinib and palbociclib for patients being treated for mantle cell lymphoma. Read more
2017 Jan 27
Jaffrey wins Abel Award
Dr. Samie Jaffrey, the Greenberg-Starr Professor and a professor of pharmacology at Weill Cornell Medicine, has received the 2017 John J. Abel Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics. Read more
2017 Jan 27
Cantley elected as board chair of Hope Funds
Meyer director Lewis Cantley, Ph.D., was recently elected as Chairman of the Board of Trustees of the Hope Funds for Cancer Research, a charity dedicated to advancing innovative research for the most difficult-to-treat cancers. Read more
2017 Jan 27
Stopping gliomas in their tracks
Drugs currently used to treat myeloproliferative disorders may help halt brain cancer before it becomes incurable. Read more
2017 Jan 27
GPS for CAR-T
Moonsoo M. Jin, Ph.D., and colleagues at the Molecular Imaging Innovations Institute, have developed a method to map infused T cells throughout the body, which could improve the safety and efficacy of immunotherapy. Read more
2017 Jan 25
We Are Weill Cornell Medicine: Dr. Heather Yeo
Heather Yeo, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Jan 25
A prostate cancer that sidesteps therapy
Feature about the work of Himisha Beltran, M.D., to uncover the evolution of aggressive forms of prostate cancer. Read more
2017 Jan 18
Cantley named as NCI Outstanding Investigator
Meyer director Lewis Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism. Read more
2017 Jan 17
Ofatumumab improves overall response in Waldenström macroglobulinemia
A study by Richard Furman, M.D., found that ofatumumab may be a non-chemotherapeutic option for patients with Waldenström macroglobulinemia. Read more
2017 Jan 17
My visit to the medical Holodeck
Feature about the use of virtual reality for cancer research at Weill Cornell Medicine. Read more
2017 Jan 13
Anti-science culture is growing, say Nobel Laureates
Harold Varmus, M.D., warned against the "anti-science movement" during a visit to India for the Nobel Prize Series. Read more
